arginine has been researched along with Cervix Dysplasia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baena, A; Bedoya, AM; Borrero, M; Córdoba, CM; Herrero, R; Pareja, R; Patterson, JR; Rojas, F; Sanchez, GI; Tate, DJ; Zea, AH | 1 |
| Herman, B; Jayaprakash, PG; Pillai, MR; Pollock, BH; Sreevidya, S | 1 |
| Coutlée, F; Duarte-Franco, E; Forest, P; Franco, EL; Ghosh, A; Koushik, A; Matlashewski, G; Voyer, H | 1 |
| Herzog, RE | 1 |
| Hittelman, WN; Hong, WK; Lee, JJ; Lotan, R; Mitchell, MF; Nishioka, K; Tortolero-Luna, G; Wharton, JT | 1 |
| Campbell, I; Gornall, R; Lanham, S; Watt, P | 1 |
| Buys, CH; Hayes, VM; Hofstra, RM; Hollema, H; van der Zee, AG | 1 |
| Børresen-Dale, AL; Helland, A; Johnsen, H; Langerød, A; Olsen, AO; Skovlund, E | 1 |
| Giannoudis, A; Graham, DA; Herrington, CS; Southern, SA | 1 |
| Agorastos, T; Bontis, JN; Constantinidis, TC; Kotsis, A; Lambropoulos, AF | 1 |
| Andersson, S; Delius, H; Edler, L; Klimek, F; Marongiu, A; Tommasino, M; Voglino, G; Wilander, E; Zehbe, I | 1 |
1 trial(s) available for arginine and Cervix Dysplasia
| Article | Year |
|---|---|
Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Arginine; Biogenic Polyamines; Dose-Response Relationship, Drug; Drug Administration Schedule; Eflornithine; Enzyme Inhibitors; Female; Humans; Ornithine; Ornithine Decarboxylase; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1998 |
10 other study(ies) available for arginine and Cervix Dysplasia
| Article | Year |
|---|---|
Immunosuppression in cervical cancer with special reference to arginase activity.
Topics: Adult; Aged; Arginase; Arginine; Carcinoma, Squamous Cell; Female; Humans; Immune Tolerance; Middle Aged; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2014 |
Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
Topics: Arginine; Carcinoma, Squamous Cell; Codon; DNA Primers; DNA, Neoplasm; DNA, Viral; Female; Genes, p53; Genotype; Homozygote; Humans; India; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2002 |
The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia.
Topics: Adult; Arginine; Canada; Case-Control Studies; Codon; DNA, Neoplasm; Female; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Odds Ratio; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Proline; Risk Factors; Sequence Analysis, DNA; Tumor Suppressor Protein p53; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2005 |
Cytophotometric determinations of DNA, histone, arginine, lysine, and their concentrations in eu- and heterochromatin of the cell nucleus of dysplasias, carcinoma in situ, and carcinoma of the human cervix uteri.
Topics: Arginine; Carcinoma; Carcinoma in Situ; Cell Nucleus; Chromatin; DNA, Neoplasm; Female; Heterochromatin; Histones; Humans; Lysine; Mathematics; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1982 |
p53 polymorphism and risk of cervical cancer.
Topics: Alleles; Arginine; Case-Control Studies; Female; Genes, p53; Humans; Polymorphism, Genetic; Prevalence; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1998 |
Homozygous arginine-72 in wild type p53 and risk of cervical cancer.
Topics: Alleles; Arginine; Cell Transformation, Neoplastic; Female; Genetic Predisposition to Disease; Homozygote; Humans; Neoplasm Staging; Papillomaviridae; Papillomavirus Infections; Proline; Risk Factors; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1998 |
p53 polymorphism and risk of cervical cancer.
Topics: Alleles; Arginine; Breast Neoplasms; DNA-Binding Proteins; Female; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Humans; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Repressor Proteins; Risk Factors; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1998 |
p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix.
Topics: Arginine; Carcinoma, Squamous Cell; Condylomata Acuminata; Female; Genes, p53; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Oncogene Proteins, Viral; Papillomaviridae; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1999 |
p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women.
Topics: Adult; Arginine; Codon; Confidence Intervals; Female; Genes, p53; Genotype; Greece; Humans; Middle Aged; Odds Ratio; Polymorphism, Genetic; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2000 |
p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
Topics: Arginine; Codon; Cohort Studies; Cross-Sectional Studies; DNA Mutational Analysis; DNA, Neoplasm; Female; Genotype; Humans; Italy; Neoplasm Invasiveness; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Repressor Proteins; Risk Factors; Sweden; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2001 |